{"id":"W2906270512","doi":"10.1016/j.jval.2018.09.258","title":"PCN175 - BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN’S LYMPHOMA: A COST-EFFECTIVENESS ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Hodgkin's lymphoma; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Chemotherapy; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002869323,0.001568883,0.002920785,0.001233586,0.0002176129,0.001510269,0.001095297,0.00121545,0.004170104],"category_scores_gemma":[0.004698615,0.0005743073,0.007596905,0.001176254,0.0007544722,0.001774854,0.0007389635,0.002211547,0.0001642689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00359658,"about_ca_system_score_gemma":0.001344676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00499593,"about_ca_topic_score_gemma":0.00542159,"domain_scores_codex":[0.997491,0.001703605,0.000134999,0.0002008508,0.0002202793,0.0002493802],"domain_scores_gemma":[0.997955,0.001416193,0.0002995325,0.0000580404,0.00005407046,0.0002170857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7638793,0.00351329,0.01395267,0.005240675,0.03258627,0.0004103129,0.0001196357,0.04545427,0.001833473,0.001487078,0.001208445,0.1303146],"study_design_scores_gemma":[0.3596437,0.2982413,0.0866379,0.002444902,0.1297898,0.001495254,0.0008550314,0.1068984,0.002986947,0.004837792,0.005829154,0.0003399634],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.955222,0.0359095,0.002086377,0.0008292295,0.0003162052,0.0009538541,0.001677513,0.00005489239,0.002950405],"genre_scores_gemma":[0.9954233,0.00281566,0.0007402367,0.0001615546,0.00005660488,0.0001319401,0.000396328,0.000005091477,0.0002693282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00499593,"threshold_uncertainty_score":0.02609509,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0442223567368915,"score_gpt":0.3657062456429737,"score_spread":0.3214838889060822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}